US: ADYX - Adynxx Inc

Yield per half year: 0%
Dividend yield: 0.00%

Share chart Adynxx Inc

Extended chart Simple chart
Financial Markets by TradingView

About Adynxx Inc

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN US00784D1037
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.adynxx.com
Цена ао 0.0001
Change price per day: 0% (0.0001)
Change price per week: 0% (0.0001)
Change price per month: 0% (0.0001)
Change price per 3 month: 0% (0.0001)
Change price per half year: 0% (0.0001)
Change price per year: 0% (0.0001)
Change price per 3 year: -99.76% (0.0411)
Change price per 5 year: -100% (2.48)
Change price per 10 year: 0% (0.0001)
Change price per year to date: 0% (0.0001)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.5 5
Total: 2.35

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -53.7 0
Yield Ebitda, % -93.16 0
Yield EPS, % -95.64 0
Total: 0
More

Head Job title Payment Year of birth
Mr. Richard Orr Esq., J.D. President, CEO, Principal Financial Officer & Director 1961 (64 years)
Dr. Julien Mamet Ph.D. Founder, Chief Scientific Officer & Director 1976 (49 years)
Mr. William Martin Executive Vice President of Corporate Development & Operations
Ms. Dina Gonzalez Principal Accounting Officer & Senior VP of Finance
Ms. Kimberley Hebert Senior Director of Clinical Operations

Address: United States, San Francisco, 100 Pine Street - open in Google maps, open in Yandex maps
Website: https://www.adynxx.com